ArticleOncogenesis2023

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer.

Mariusz Shrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.